BREXAFEMME® (ibrexafungerp tablets), for oral use

BREXAFEMME® (ibrexafungerp tablets), for oral use

A novel oral antifungal approved for the treatment of vulvovaginal candidiasis (VVC), also known as vaginal yeast infection

Format

JPEG

Source

Scynexis

Downloads

About Us

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases, financial disclosures and multimedia content to media, investors, and consumers worldwide.

Global News
Newswire Distribution Network & Management

© 2025 Digital Media Innovations, LLC. All rights reserved.